Global Cardiac Mapping Market

Cardiac Mapping Market Size, Share, Growth Analysis, By End user(Hospitals & Clinics, Diagnostic Centers), By Product(Contact Cardiac Mapping Systems, and Non-Contact Cardiac Mapping Systems), By Indication(Atrial Fibrillation, Atrial Flutter) - Industry Forecast 2024-2031


Report ID: SQMIG35A2783 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 90 | Figures: 73

Cardiac Mapping Market Dynamics

Drivers

Rising Number of Cardiovascular Diseases

  • The anticipated growth in market revenue for cardiac mapping systems is underpinned by two key factors: the rising likelihood of an increase in cardiovascular disorders and the continuous technological advancements in cardiac mapping diagnostics. According to the World Health Organisation (WHO), cardiovascular diseases (CVDs) stand as the leading cause of global mortality, responsible for approximately 17.9 million deaths annually. Notably, more than four out of every five CVD-related fatalities are attributed to heart attacks and strokes, with a significant proportion occurring in individuals under the age of 70.

Restraints

  • Increasing Trend in Complex Treatment of Cardiac Imaging

The cardiac mapping market faces a remarkable hurdle due to the prevailing tendency toward complex procedures associated with cardiac imaging; this trend has been identified as the major restraining factor affecting the revenue of the market so one of the. Difficulties with cardiac imaging protocols pose challenges, which may impede widespread adoption and availability. However, the integration of modern electrophysiological mapping systems, the use of sophisticated technologies in electrophysiological catheter manufacturing, and advances in cardiac imaging techniques have seen a good balance in the market. The use of A wide range of mapping strategies and techniques are possible during electrophysiological procedures.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cardiac Mapping Market size was valued at USD 1.86 billion in 2022 and is poised to grow from USD 2.03 billion in 2023 to USD 4.01 billion by 2031, growing at a CAGR of 8.90% during the forecast period (2024-2031).

The competitive environment of the Cardiac Mapping market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 'Biosense Webster (U.S.)', 'Boston Scientific Corporation (U.S.)', 'Medtronic (Ireland)', 'Abbott (U.S.)', 'BIOTRONIK (Germany)', 'MicroPort Scientific Corporation (China)', 'Acutus Medical Inc. (U.S.)', 'Catheter Precision (U.S.)', 'Koninklijke Philips N.V. (Netherlands)', 'EP Solutions (Switzerland)', 'Lepu Medical Technology Co. Ltd. (China)', 'AngioDynamics (U.S.)', 'BioSig Technologies (U.S.)', 'APN Health (U.S.)', 'CoreMap (U.S.)', 'Kardium (Canada)', 'Epmap-System (Germany)'

The anticipated growth in market revenue for cardiac mapping systems is underpinned by two key factors: the rising likelihood of an increase in cardiovascular disorders and the continuous technological advancements in cardiac mapping diagnostics. According to the World Health Organisation (WHO), cardiovascular diseases (CVDs) stand as the leading cause of mortality, responsible for approximately 17.9 million deaths annually. Notably, more than four out of every five CVD-related fatalities are attributed to heart attacks and strokes, with a significant proportion occurring in individuals under the age of 70.

During the forecast period, the cardiac imaging market is expected to witness substantial growth driven by multiple factors. Medical device companies are expected to play a key role in this trend as cutting-edge diagnostic technologies are increasingly adopted. Increasing demand for accurate cardiac testing has been identified as another major driver The growth is great because of its expansion.

The North American cardiac mapping market is poised to assert its dominance, driven by several key factors. The region's leading position is attributed to the high prevalence of Cardiovascular Diseases (CVDs), a health concern that has prompted an increasing acceptance rate of cardiac mapping systems in the United States. The validation of these systems through clinical trials further contributes to the robust demand growth anticipated over the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cardiac Mapping Market

Product ID: SQMIG35A2783

$5,300
BUY NOW GET FREE SAMPLE